Sector ratings Charles River Laboratories International, Inc.

Stocks

Market Closed - NYSE 06:00:02 29/08/26 am AEST			5-day change	1st Jan Change
291.50 ^USD	-1.66%		-1.25%	+46.13%

21/08	Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing	MT
20/08	Charles River, Medigen Partner on Multivalent Enterovirus Vaccine	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	13.92B		AA
LONZA GROUP AG	50.47B		AAA
REVOLUTION MEDICINES, INC.	44.56B	-	B	-	-
IQVIA HOLDINGS INC.	43.08B		AAA
BEONE MEDICINES AG	41.7B		-
CELLTRION, INC.	33.21B		A
MEDPACE HOLDINGS, INC.	16.77B		BBB
ASCENDIS PHARMA A/S	16.28B	-	-	-	-
EUROFINS SCIENTIFIC SE	14.58B		AA
ICON PUBLIC LIMITED COMPANY	13.12B		AAA
TEMPUS AI, INC.	11.56B		A		-
BIO-TECHNE CORPORATION	11.35B		AA
PHARMARON BEIJING CO., LTD.	10.96B		AA
ABIVAX	10.58B	-	BBB	-	-
APOGEE THERAPEUTICS, INC.	10.18B	-	B	-	-
IONIS PHARMACEUTICALS, INC.	10.15B	-	A	-	-
KYMERA THERAPEUTICS, INC.	9.82B	-	BBB	-	-
GENSCRIPT BIOTECH CORPORATION	9.77B		AA		-
PRAXIS PRECISION MEDICINES, INC.	9.63B	-	B	-	-
PROTAGONIST THERAPEUTICS, INC.	9.34B		BB		-
Average	19.55B		A
Weighted average by Cap.			A